explore -WSS

explore

author：knowledge 2025-10-08 16:14:50 - browse：8

Adobe

At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the Food and Drug Administration announced in a recall notice on Wednesday.

The product is made by Tandem Diabetes Care, which sells touchscreen insulin pumps and an accompanying app to help dose the medicine. Around 300,000 people use the technology. Tandem found that a bug in the app’s software is causing the app to repeatedly crash and relaunch, draining the insulin pump’s battery through unnecessary Bluetooth communication.

An insulin pump shutting down unexpectedly could kill people, especially if the shutdown occurs while the person is sleeping. There have been no reports of death so far, the FDA said. Tandem users commiserated over the issue on Reddit two months ago, with one user describing waking up at 2 a.m. to a dead pump. “Infuriating,” the user wrote. “Absolutely should be sending a notice out to all customers about this.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： How generative AI ratchets up security threats for health systems

hotspot

WSS

Health Care Service Corp to buy Cigna Medicare Advantage plans

Venture capital firm's plans to take over Akron hospital face hurdles

FTC sues over Novant Health acquisition of two N.C. hospitals

Biogen walks away from Aduhelm, years after polarizing approval

Philips to halt sales of sleep apnea machines in U.S.

Why you shouldn’t ask, “What country has the best health care?”

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

10 reasons why health care startups fail

Wildfire smoke exposes gaps in outdoor worker protections

Venture capital firm's plans to take over Akron hospital face hurdles

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why you shouldn’t ask, “What country has the best health care?”

Peter Hotez and the public health issue of online harassment

Merck CEO won’t testify in Senate, citing no expertise in drug prices

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

leisure time

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Merck, Johnson & Johnson CEOs will testify on high drug prices

New clues to why women have higher risk of autoimmune disorders

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Bernie Sanders is gearing up to subpoena pharma CEOs

Zyn nicotine pouches become unlikely player in latest culture war

hotspot

leisure time

hotspot

focus